Ewing's sarcoma (ES) is a rare, highly malignant anaplastic stem cell tumor of neuroectodermal origin, also classified as round-cell sarcoma, to which the primitive neuroectodermal tumors also belong. It mainly arises from the bone.
bones (11%) (►Fig. 3).
1 Other localizations are the fibula (7%) (►Figs. 4 and 5) and ribs (6%) (►Fig. 5). ES can virtually involve all bones of the body and may also involve extraskeletal sites (►Fig. 1). An isolated involvement of the soft tissue (extraskeletal ES) was observed in 1.5% of all cases in a series of 64 patients. 2 Compared with osteosarcoma, flat bones are more often affected in ES. Rarely, a bicentric ES or synchronous involvement of multiple bones may be seen (►Fig. 6), whereas transarticular spread can rarely be seen in sacroiliac joints. 3 Up to 15% of all ES cases are localized in the vertebral column, with the lumbar spine and the sacrum as the most commonly affected; the location of ES tends to follow the distribution of red marrow. The mean age at initial clinical presentation is 19.3 years, slightly higher than the mean age of ES of the extremity bones. 4 Metastases of ES affecting the vertebral column are more common than a primary ES of the spine.
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Pathology
Macroscopically, the tumor has the aspect of fish flesh. At histology, the tumor consists of uniform densely packed small monomorphic cells with round nuclei that are generally larger than in primary osseous lymphoma. The typical appearance at hematoxylin and eosin (H&E) staining is small blue round cells without any matrix formation (►Fig. 2). At immunostaining, an expression of the cellular surface antigen CD99, a product of the MIC-2 gene, is characteristic. The characteristic reciprocal translocation between chromosome 11 and 22 (t[11;22] ), which affects in 85% the EWS and FLI1 gene, can be confirmed by using break-apart fluorescence in situ hybridization (►Fig. 2).
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Imaging
Conventional radiography (CR) reveals an aggressive osteolytic lesion with a wide zone of transition and with a moth-eaten or permeative pattern in most cases. 8 In a series of 64 patients, most tumors were mixed lytic-sclerotic (in 75%) and purely lytic in 25%. 2 Complex periosteal reactions like onion-skinned, spiculae, "sunburst," or Codman's triangle can be seen (►Fig. 5) in 27 to 50% of all cases. 2 Onion-skinned or multilamellated periosteal reactions may be encountered in 25% of cases. Computed tomography (CT) is more sensitive than CR to detect bony destruction in anatomically complex regions such as the vertebral column and the pelvic bones due to the lack of superimposition. In flat bones such as the pelvic bones, ES may have a predominantly sclerotic appearance (►Fig. 3) that overall represents $ 10% of cases. The reason for the sclerotic appearance is mainly necrotic bony changes because tumorrelated formation of new bone is not a histologic feature of ES.
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Magnetic resonance imaging (MRI) is the method of choice for local staging because it demonstrates the true tumor extension (►Figs. 4, 5, 6, 7) . The MRI protocol has to cover the entire tumor extent as well as the adjacent joints and the entire bone where the tumor originates because skip lesions (►Fig. 5), which when present have great influence on the treatment planning, are frequent. Skip metastases at initial presentation were present in 14% of all cases in a series of 64 patients. 2 The signal intensity of the tumor tissue of the ES is hypointense on T1-weighted images and hyperintense on T2-weighted images. A large soft tissue component is highly characteristic (96% of all cases), 8 showing marked contrast enhancement. 2 Focal areas of cortical destruction are frequent (92% of all cases), 8 allowing continuity between the intraosseous and extraosseous components (►Figs. 5, 6, 7) . This continuity is also commonly seen as subtle channels extending through the cortex at MRI, a finding that reflects the underlying pathologic appearance 8 because the communication between the medullary canal and soft tissue components may be through focal cortical destruction or more commonly through permeation of the cortical haversian canal system and along neurovascular channels with small nests of tumor cells. Extraskeletal ES commonly demonstrates a nonspecific radiologic appearance of a large soft tissue mass affecting the paraspinal region or lower extremity, 8 and it may be occult on CR (►Fig. 1). Another imaging characteristic that may occur in ES as well as osseous lymphoma is the so-called wraparound sign. This means that the cortex at T2-weighted images appears regularly hypointense, although there is a large soft tissue component that appears to be wrapped around the bone. This is believed to be due to the permeative growth of the tumor so that the calcified bone is not destroyed to a major extent (►Figs. 4, 5, 6, 7). Because ES most often metastasizes hematogenously into the lung (although lymphatic and osseous spread may also occur but is rare; the incidence of regional node involvement is $ 3% in skeletal ES 9 ), staging consists of CT of the thorax and abdomen as well as bone scintigraphy or positron emission tomography (PET) using fluorodeoxyglucose (FDG) as a tracer to detect or exclude metastases. In 25% of all cases, there are metastases present at the time of diagnosis of ES. According to the EWING 2008 study, 10 initial imaging of ES consists of MRI for local staging, chest CT, whole-body scintigraphy, and FDG-PET. After completion of imaging, the final diagnosis will be verified at histology and by genetic markers from biopsy material. Biopsy should be performed in a dedicated sarcoma treatment center.
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Differential Diagnosis
In general, all tumors consisting of small round blue cells may have similar imaging features. The main differential diagnoses consist of osteolytic osteosarcoma and small-cell osteosarcoma in children and adolescents, osteomyelitis in all age groups, and non-Hodgkin's lymphoma in adulthood.
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In children, unifocal Langerhans cell histiocytosis is another differential, but the periosteal reaction is often less aggressive, and an eosinophilic granuloma may have a sequestrum.
In the spine, ES may mimic spondylitis because of its high signal intensity in T2-weighted images, 4,13 whereas in the rare case of sacroiliac joint involvement, it should be distinguished from septic sacroiliitis (►Fig. 7).
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Therapy and Treatment Monitoring
Treatment is interdisciplinary and consists of induction chemotherapy and local therapy with subsequent chemotherapy and/or radiation therapy within multicentric study protocols. 14,15 Such multicentric study protocols are, for instance, the EURO-EWING 99 (six cycles of induction chemotherapy followed by local therapy, and adjuvant chemotherapy using different regimens according to the individual patient's risk factors) or the EURO-EWING 2008 study (►Figs. 4 and 6).
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For the latter, neoadjuvant chemotherapy with histopathologic assessment of tumor response to induction neoadjuvant Ewing's Sarcoma and Primary Osseous Lymphoma Weber et al. 41
chemotherapy, followed by local therapy like surgical tumor resection and reconstruction, and optionally followed by radiation therapy is recommended. Radiation therapy alone as local therapy is the therapy of choice whenever surgery is not possible but has the drawback of a higher local recurrence rate. A second chemotherapy phase as adjuvant chemotherapy is followed in a risk-adapted way. The success of neoadjuvant chemotherapy is assessed locally by using CR and MRI and FDG-PET (according to EURO-EWING 2008) to assess therapy response and local recurrence (►Fig. 4). . Note a hair-on-end periosteal reaction at the ulnar and palmar aspect of the diaphysis of the radius on plain radiographs. On CT, the extent of the periosteal reaction is more obvious and shows that both the palmar and dorsal side of the radius are involved. Note also focal irregular delineation of the dorsal cortex of the radius. Projection radiographs in (e) AP and (f) lateral view of ES of the left fibula in an 11-year-old boy. There is fusiform bone expansion of the diaphysis of the fibula with a distinct periosteal reaction with a variable pattern, consisting of partially onion-skinned and partially perpendicular (sunburst pattern) to the underlying cortex. The lesion has a mixed appearance with areas of osteolysis, cortical destruction, and sclerotic areas. ES of the left femur with onion-skin periosteal reaction (arrow), fusiform bone expansion of the diaphysis, and ill-defined osteolysis with cortex permeation on (g) projection radiography, (h) large soft tissue component (arrow) and wraparound sign on axial T2-weighted fatsuppressed MRI, and (i) skip lesion (arrow) in the femur diaphysis depicted by unenhanced coronal T1-weighted MRI. ES of the left lower thoracic rib cage in a 12-year-old boy. There is cortical destruction of the rib with large associated soft tissue mass extending in the pleura, left paravertebral muscles and left neuroforamen. The lesion is inhomogeneous on T2-weighted image with fat suppression with areas of low to intermediate signal intensity and hyperintense areas. There is vivid enhancement of the lesion; (j) sagittal T2-weighted, (k) axial T1-weighted, and (l) contrast-enhanced fat-saturated T1-weighted sequences.
Dynamic contrast-enhanced MRI may help differentiate residual or recurrent tumor from posttherapeutic changes because tumor tissue enhances early and more rapidly during the first pass of contrast, whereas reactive tissue resulting from posttherapeutic changes enhances later and more slowly.
18 Low-dose CT of the chest is recommended in adults for pulmonary follow-up; in children a chest radiograph may be enough. Most relapses occur in the first 3 years of follow-up; late relapses have rarely been observed even after ! 15 years. Follow-up intervals should be 2 to 3 months during the first 3 years, 6 months until 5 years, and at least once yearly thereafter according to the clinical recommendations of the European Society for Medical Oncology.
19
Overall, the 5-year-survival rate is $ 64% (up to 75% in those patients who present without known metastases). ) has to be distinguished from a secondary bone involvement by lymphomas arising from visceral organs or lymph nodes. The primary non-Hodgkin's lymphoma of the bone is an aggressively growing tumor consisting of malignant lymphatic cells that affects a single bone with or without regional lymphadenopathy. The polyostotic PBL is defined as multifocal but exclusive involvement of the skeleton, whereas the disseminated lymphoma affects various organs with or without secondary involvement of the skeleton. 23 Thus for the correct categorization of an osseous lymphoma, the radiologist's role is to exclude simultaneous extraosseous manifestations of lymphoma at other localizations. Primary osseous lymphomas are most commonly highly malignant Bcell lymphomas.
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Demography
PLB is an uncommon clinical entity and a rare presentation of non-Hodgkin's lymphoma. It can occur at any age, but it has a wide age peak between 30 and 60 years. 24, 25 An overall median age of 45 years (range: 7-87 years) was reported in a study on 119 patients with a female-to-male ratio of 1:1.53. 25 PLBs represent 3 to 5% of all malignant bone tumors, 4 to 5% of extranodal lymphoma, and < 1% of all nonHodgkin's lymphoma. 26 Diffuse large B-cell lymphoma Ewing
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(DLBCL) accounts for most cases of primary osseous lymphomas. DLBCL usually associates with single bone involvement, whereas the less frequent types, like B-lymphoblastic lymphoma, are associated with multifocal involvement. Primary osseous lymphoma is uncommon in children and adolescents.
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Clinical Manifestations
The leading symptom is local pain. General symptoms such as fever, night sweats, and fatigue that appear frequently in extraskeletal lymphomas are typically not frequently observed in PLBs.
Localization
Approximately 50% of all PLBs are localized within the skeleton of the trunk and skull; the other 50% are situated in the long bones, especially the femur (►Fig. 8); in general, bones containing red marrow are affected. Of the latter, two thirds are localized at the metaphysis and one third at the diaphysis. Epiphyseal involvement is rare. 28 About 80% of PLBs are observed unifocally within the bone (►Fig. 9). 24 In a 2014 study, the femur was the most commonly involved single site in PLBs, whereas those with multifocal bone lesions most frequently presented with spine disease (►Figs. 8 and 10). 29 Secondary lymphomas also favor the spine and should be distinguished from primary multifocal lymphoma.
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Pathology
PLBs have an indistinct tumor margin and show an invasive diffuse growth pattern. The bony cortex nearly always is infiltrated and also mostly penetrated. The pattern of extensive marrow disease and surrounding soft tissue masses but without extensive cortical destruction was reported nearly exclusively in round-cell tumors such as PLB, multiple myeloma, and ES. 31 An explanation for this finding is the spread of tumor cells from the marrow through small vascular channels that run through the cortex into the surrounding soft tissue. 31 On H&E histologic staining, the tumor stroma consists of diffuse round-cell infiltrates. This aspect resembles the appearance of ES. The diffuse infiltrates cause secondary bone resorption. At immunohistochemical analysis, nearly all lymphomas express common leukocyte antigen and B-cell markers like CD20 (►Fig. 10).
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Imaging
On CR or CT, PLBs may appear as solitary osteolytic or multiple osteolytic lesions with an aggressive destruction pattern (►Fig. 9). Similar to ES, the permeative and moth-eaten destructive pattern is an indication of the presence of a tumor consisting of small or round cells. The periosteal reaction, reported in $ 60% of cases, is often aggressive and may be complex. 31 CT may be useful to demonstrate bony destruction and, if present, a sclerosing pattern within the spine and pelvis (►Fig. 11). Osteosclerotic changes may be observed as well; however, predominant osteosclerosis is unusual in primary osseous non-Hodgkin's lymphomas. 24, 32 A sequestrum within a lucent lesion occasionally is seen and is optimally visualized on CT, although it is a nonspecific finding.
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In the spine, the often multisegmental lesions may appear osteolytic or mixed osteolytic and sclerotic (►Fig. 10). Although osseous lymphoma was classically considered in the differential diagnosis of an ivory vertebra, this is a relatively rare occurrence. 33, 34 The mixed sclerotic-lytic type is more common in secondary lymphomas and after treatment.
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However, radiographic findings may be very subtle even in the presence of aggressive appearance on other imaging modalities (►Fig. 12). Ewing's Sarcoma and Primary Osseous Lymphoma Weber et al. 45 9 Primary osseous B-cell non-Hodgkin's lymphoma in a 22-year-old man with painful swelling and tenderness of the right fibula head for 4 months, with no prior trauma and no fever. Projection radiography in (a) anteroposterior (AP) and (b) lateral view without obvious evidence of bony pathology. Projection radiography in (c) AP and (d) lateral view 6 weeks later clearly shows the destructive osteolysis of the fibular head (arrows). (e) MRI coronal T1-weighted, (f) sagittal T2-weighted, (g) coronal contrast-enhanced fat-saturated T1-weighted, (h) sagittal, (i) axial proton-density-weighted fat-saturated, and (j) axial contrast-enhanced fat-saturated T1-weighted sequences also illustrate the cortex exceeding infiltration and the wraparound sign (arrows). Staging was performed with scintigraphy (k) and contrast-enhanced CT (coronal reformation (l)) of the trunk, both showing no evidence of other skeletal or extraskeletal manifestations of lymphoma. Four months after six cycles of R-CHOP chemotherapy, whole-body MRI was performed for follow-up assessment (m, n) (coronal short tau inversion recovery), demonstrating a slight reduction of tumor size within the fibular head and no other manifestations of the lymphoma. Treatment was continued by radiotherapy with a total 32 Gy to the fibula.
spinal nerves. The signal behavior itself is nonspecific and may also show a diffuse or focal replacement of normal bone marrow, as could be seen in multiple myeloma (►Fig. 12). Lymphoma of the deep soft tissues usually reveals long cones of intramuscular or intermuscular tumor, again best depicted by MRI. Cortical destruction allowing communication between the intraosseous and soft tissue components may be subtle with small striations of extension. 36 Similar to ES, a wraparound sign may be observed consisting of an often large soft tissue component encasing the bone while the cortical bone appears preserved on MRI (►Fig. 13). In reality, the tumor has penetrated the cortex in a permeative way. Contrast-enhanced CT should be used for staging and detection of other organ manifestations (►Fig. 14). A bone scintigraphy may demonstrate the local osseous involvement and other bony manifestations of the lymphoma. The sensitivity to detect multifocal disease is lower than that of whole-body MRI. FDG-PET is well suitable for staging and treatment monitoring, but whole-body MRI (including diffusion-weighted imaging) may also be used for this purpose (►Fig. 9); both have similar performance for the detection of bone marrow involvement.
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Differential Diagnosis
For differential diagnosis, the patient's age is the crucial parameter. Typical differential diagnoses in young patients include ES, unifocal Langerhans cell histiocytosis, and osteolytic osteosarcoma. In elderly patients, typical differential diagnoses comprise metastases (for instance of small-cell tumors like bronchial carcinoma), fibrosarcoma, and osteomyelitis. In aggressive osteomyelitis with a Lodwick grade II or III appearance, 39, 40 clinical presentation may favor Ewing's Sarcoma and Primary Osseous Lymphoma Weber et al. 49 inflammation. For confirmation of the final diagnosis, biopsy sampling and imaging correlation is always mandatory (►Figs. 13, 15, and 16).
Therapy and Treatment Monitoring
The mainstay of treatment is polychemotherapy (►Fig. 13) and radiotherapy. 24, 31 Surgery is only indicated in case of complications, such as for instance in the case of pathologic fractures 41 or spinal cord compression with neurologic deficits. The most common chemotherapy regimen for aggressive non-Hodgkin's lymphoma is cyclophosphamide, hydroxydaunorubicin (doxorubicin), oncovin (vincristine), and prednisone/prednisolone (CHOP). It was recently reported that primary osseous DLBCL had a 3-and 5-year progression-free survival of 61.2% and 46.9%, respectively, and 5-and 10-year overall survival of 81.1% and 74.7%, respectively. Multivariate analysis identified soft tissue extension and the International Prognostic Index score as the most important unfavorable prognostic factors. 29 Also, multifocality was also significantly associated with a worse progression-free survival and overall survival, and the authors concluded that multifocal bone involvement is more similar to secondary bone lymphoma in characteristics and survival rather than unifocal bone disease, and thus it should be better classified and treated similar to the secondary bone lymphomas. 42 Extraskeletal involvement and older age are adverse prognostic factors. For systemic lymphoma with bone involvement, disease-free 5-year survival is 44%.
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Conclusion
The typical manifestation of ES is a permeative lesion in the diaphysis of a long bone in a child. However, the imaging appearance in projection radiography may be diverse, and ES has been called the chameleon of the bone tumors. Extraskeletal ES may be missed on CR and will best be depicted by MRI. There is no single characteristic imaging appearance of an osseous lymphoma. An osseous lymphoma should be considered in the differential diagnosis when encountering in an adult a Lodwick grade II or III osteolytic lesion in the metaphysis or diaphysis of a large long bone, the pelvis, or the vertebral column that may be accompanied to a greater or lesser extent by sclerotic bony changes. Similar to ES, PLB may also be called the chameleon of the bone tumors. In general, permeative and moth-eaten destructive patterns of the bone Ewing's Sarcoma and Primary Osseous Lymphoma Weber et al. 51 are a hint for a small-or round-cell tumor. Histologic confirmation should always be sought. Because patients with remarkably normal-appearing CR may show distinct abnormalities on MRI or bone scintigraphy, in patients with persisting symptoms but negative CR, further assessment with a more sensitive modality, such as MRI, is essential. 
